
Associate Professor,
Division of Pediatric Clinical Immunology & Rheumatology,
Christian Medical College, Vellore, India
Inborn Errors of Immunity (IEI), formerly known as Primary Immunodeficiency Disorders (PID), encompass a spectrum of conditions characterised by recurrent infections, autoimmunity, autoinflammation, allergies, and malignancies. Contrary to the traditional belief that IEIs/PIDs primarily affect young children, recent evidence highlights their relevance in adults as well. Table 1 outlines common misconceptions related to the suspicion and diagnosis of IEIs/PIDs. In this letter, I will discuss a pattern-based diagnostic approach to specific IEIs, focusing on the characteristic infection patterns associated with each.
The classical teaching of PIDs into 4 major subgroups still holds its value today. It is divided into predominant B-cell defects, predominant T-cell defects, Granulocytic (neutrophil) defects, and Complement deficiencies. Clinical pattern recognition comprises age, the system affected, and the organisms involved. Table 2 summarises the pattern recognition steps for diagnosing PIDs [Common PIDs, though the list is not exhaustive], using age, infection patterns, and microorganisms. Although age usually aids in classifying/diagnosing certain types of PIDs, hypomorphic variants may present at any age.
With the discovery of more IEIs/PIDs, as well as an expanding understanding of innate immune defects and the role of auto-cytokine antibodies (phenocopies of PIDs), the relationship between specific pathogens and PIDs has become increasingly complex, not as simple as illustrated in Table 2. Table 3 provides an expanded overview of the most common pathogens and their associated PIDs. However, it is crucial to interpret these associations within the appropriate clinical context. Diagnosis should not rely exclusively on the identification of causative organisms; rather, a comprehensive clinical, necessary lab assessment remains vital. For example, certain opportunistic infections are frequently seen in intensive care settings, and adults with diabetes or secondary immunodeficiency are susceptible to specific infections: factors that must always be considered during evaluation.
Table 1: Common misconceptions
Myth | Brief Rationale/ Justification |
PIDs are rare | ~1 in 1200-10000 persons might have PIDs (US survey) |
PIDs are very rare in adults | ESID registry (16,486 patients): Two-thirds had first symptoms before 6 years of age, but about a quarter first developed symptoms in adulthood |
PIDs should have repeated infections | Infection is the commonest presentation but not universal: ESID registry (16,486 patients): Infections alone (68%); however, if only repeated infections alone are considered to suspect PIDs, we might miss 25% of patients with PIDs |
PIDs need complex/extensive laboratory tests to diagnose | Initial detection uses basic, widely available tests; complex testing is needed mainly for confirmation |
Table 2: Pattern recognition
Age of Onset | Pattern of Infection | Key Organisms | |
T Cell Defect | 2–6 months | Oral candidiasis; viral and opportunistic infections | Bacteria, mycobacteria, viruses, Fungal, Pneumocystis (opportunistic infections) |
B Cell Defect | Starts by 5–7 months → adulthood | Recurrent sinopulmonary/GI mucosal infections | Predominant humoral bacteria (encapsulated bacteria), Mycoplasma, enterovirus, Giardia |
Granulocyte Defect | Early/neonatal | Skin infections; lymphadenitis/abscess; deep-seated abscesses; stomatitis; perianal infections | Catalase-positive organisms: Staphylococcus, Klebsiella, Burkholderia, Candida, Aspergillus, Serratia, Nocardia |
Complement Defect | Any age | Meningitis; bacteremia; pneumonia; invasive infections | Capsulated organisms: Pneumococcus, Neisseria |
Signature microorganism / infectious phenotype | Predominant IEI |
Chronic/recurrent Candida of nails, oral cavity, skin or genital mucosa | STAT1 GOF; AIRE/APECED; STAT3-HIES; IL12RB1/IL12B; CARD9 Consider broader combined immunodeficiency if accompanied by multiple viral/opportunistic infections |
Invasive Aspergillus | CGD; CARD9 deficiency; severe congenital neutropenia and combined immunodeficiencies. |
Staphylococcus aureus recurrent skin/deep abscesses, lymphadenitis or osteomyelitis | CGD; STAT3-HIES; severe congenital neutropenia [Pseudomonas also]; LAD; IRAK4/MyD88 pathway defects. |
Disseminated BCG / environmental mycobacteria / NTM | MSMD (IL12/IFN-γ axis: IFNGR1/2, IL12B, IL12RB1, STAT1, IRF8, ISG15, etc.); GATA2 deficiency; Idiopathic CD4 lymphocytopenia; severe CID/SCID; NEMO; selected CGD. |
Invasive/non-typhoidal Salmonella | MSMD/IL12–IFN-γ pathway defects; CGD; some combined immunodeficiencies. |
CMV—severe, persistent or disseminated disease | SCID/CID; combined T-cell defects; GATA2 and selected immune-dysregulation disorders. |
Extensive/recalcitrant HPV warts | WHIM (CXCR4); DOCK8 deficiency; GATA2 deficiency; epidermodysplasia verruciformis-associated IEI; selected combined immunodeficiencies. |
Severe EBV disease, EBV-HLH or EBV-driven lymphoproliferation | XLP1/SH2D1A; XIAP/BIRC4; CD27/CD70; MAGT1; ITK; CTPS1; RASGRP1; CORO1A and related T/NK-cell defects. |
HSV-1 encephalitis in a previously healthy child | TLR3 pathway and CNS-intrinsic antiviral defects: TLR3, UNC93B1, TRAF3, TBK1, IRF3, and related pathways. |
Endemic Mycoses (Histoplasma, Coccidioides, Blastomyces) | MSMD; STAT3 deficiency; STAT1 GOF
|
Cryptococcus neoformans | GATA2 deficiency; STAT3-HIES; Autoantibodies against IFN- |
Cryptosporidium parvum | Few HIGM; SCID; MHC Class II deficiency |
Suggested Readings:
Copyright 2026 IRA eNewsLetter. All rights reserved. | Powered by BoxCloud